论文部分内容阅读
研究表明,Her-2作为肿瘤发生的癌基因,在20%~30%的侵袭性乳腺癌中过度表达,与乳腺癌的侵袭转移及预后密切相关[1]。近年来一种特异性的单克隆抗体药物Her-ceptin已运用于临床,并且用于筛选该类疾病,目前公认的方法有两种:即免疫组化(IHC)法和荧光原位杂交(FISH)法,但其结果之间
Studies have shown that Her-2 as a tumor oncogene overexpression in 20% to 30% of invasive breast cancer is closely related to the invasion and metastasis and prognosis of breast cancer [1]. In recent years, a specific monoclonal antibody Her-ceptin has been used in clinical and screening for such diseases, there are two accepted methods: immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH ) Act, but the result is between